Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Blood Specimen Collection × Clear all

Phase

Phase NA 35 Phase 2 2 Phase 1 2 Phase 4 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Thymic aplasia 1 Small Cell Lung Carcinoma 1 Pain, Postoperative 1 Neoplasms 1 Lung Neoplasms 1 Immunologic Deficiency Syndromes 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Dexamethasone 6 Oxycodone 5 Propofol 4 Epoetin Alfa 4 Zoledronic Acid 3 Sevoflurane 3 Palonosetron 3 Everolimus 3 Cholecalciferol 3 Aspirin 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vancomycin 2 Tobacco Use Cessation Devices 2 Tablets 2 Surgical Procedures, Operative 2 Saline Solution 2 Rivaroxaban 2 Ondansetron 2 Octreotide 2 Naloxone 2 Morphine 2 Metoclopramide 2 Meropenem 2 Lidocaine 2 Lenograstim 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡